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Abstract 19 
Erasure of DNA methylation and repressive chromatin marks in the mammalian germline 20 
leads to risk of transcriptional activation of transposable elements (TEs). Here, we used 21 
mouse embryonic stem cells (ESCs) to identify an endosiRNA-based mechanism involved in 22 
suppression of TE transcription. In ESCs with DNA demethylation induced by acute deletion 23 
of Dnmt1, we saw an increase in sense transcription at TEs, resulting in an abundance of 24 
sense/antisense transcripts leading to high levels of ARGONAUTE2 (AGO2) bound small 25 
RNAs. Inhibition of Dicer and Ago2 expression revealed that small RNAs are involved in an 26 
immediate response to demethylation-induced transposon activation, while the deposition of 27 
repressive histone marks follows as a chronic response. In vivo, we also found TE-specific 28 
endosiRNAs present during primordial germ cell development. Our results suggest that 29 
antisense TE transcription is a 'trap' that elicits an endosiRNA response to restrain acute 30 
transposon activity during epigenetic reprogramming in the mammalian germline. 31 
32 
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Introduction  33 
Epigenetic reprogramming in the mammalian germ line is key for restoration of 34 
developmental potency and occurs at the preimplantation stage of embryonic development 35 
and during development of primordial germ cells (PGCs) (Reik and Surani, 2015). These 36 
events lead to global DNA methylation and H3K9me2 erasure together with the transient 37 
transcriptional activation of specific classes of transposable elements (TEs) (Hajkova et al., 38 
2008, Rowe and Trono, 2011). This raises fundamental questions about the regulation of TE 39 
defence in the absence of repressive epigenetic marks. 40 
 41 
TEs comprise ~50% of the mammalian genome and can be categorised into two major 42 
classes: retrotransposons and DNA transposons (Lander et al., 2001). While most TEs in the 43 
genome are inactive due to mutations and/or truncations, around 1-2% of long interspersed 44 
nuclear elements (LINEs) and endogenous retroviruses (ERVs) remain able to 45 
retrotranspose (Maksakova et al., 2006). Notably, the ERV family members Intracisternal A 46 
Particles (IAPs) and Early Transposons (ETns) are the most active TEs in the murine 47 
germline (Maksakova et al., 2006). 48 
 49 
Due to their ability to retrotranspose, TEs are thought to play an important role in genome 50 
evolution, but can also cause genetic diseases (Goodier and Kazazian, 2008). In order to 51 
protect the genome from harmful mutations, regulatory mechanisms must be in place to limit 52 
their transcription. 53 
 54 
TE activity is controlled by multiple epigenetic mechanisms including DNA methylation, 55 
repressive histone modifications, and small RNAs (Rowe and Trono, 2011). In somatic 56 
tissues DNA methylation and H3K9me2/3 have been shown to be responsible for TE 57 
silencing (Walsh et al., 1998, Hutnick et al., 2010). However in the germ line DNA 58 
methylation and H3K9me2 are globally erased, while H3K9me3 is maintained and 59 
H3K27me3 is redistributed (Iurlaro et al., 2017, Tang et al., 2016). Indeed deletion of the 60 
H3K9me3 methyltransferase Setdb1 leads to activation of IAPs during PGC development as 61 
well as in mouse embryonic stem cells (ESCs) (Karimi et al., 2011, Maksakove et al., 2013). 62 
Further, global demethylation of naïve ESCs results in transcriptional activation of TEs and 63 
subsequent resilencing by a redistribution of repressive histone marks (Walter et al., 2016). 64 
 65 
A number of studies have demonstrated that small RNAs may also act post transcriptionally 66 
as a second-tier defence against TEs, particularly in the germline. In mouse oocytes, 67 
microRNAs (miRNAs) and endogenous short-interfering RNAs (endosiRNAs) that control TE 68 
expression have been identified (Tam et al., 2008, Flemr et al., 2013, Watanabe et al., 2006) 69 
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and in the male germline PIWI-interacting small RNAs (piRNAs)  can also control TE 70 
expression (Aravin et al., 2008). In ESCs tRNA fragments have been recently described to 71 
play a role in ERV translational control (Schorn et al., 2017). 72 
 73 
In contrast to somatic cells, increased pervasive transcription across TEs was reported in 74 
ESCs, suggesting that TEs may regulate transcription of long noncoding RNAs (Kelley and 75 
Rinn, 2012). Intriguingly however, in yeast it was shown that genome-wide pervasive 76 
transcription antisense to transposons leads to an RNA interference (RNAi) response as a 77 
defence mechanism against TEs (Cruz and Houseley, 2014). Sense/antisense transcription 78 
permits the production of double stranded RNA (dsRNA) triggering RNAi (Fire et al., 1998) 79 
which has also been identified as a control mechanism of TEs  (Robert et al., 2005). 80 
 81 
Here we test the hypothesis that genic transcripts antisense to TEs serve as a trap for 82 
transcriptional activation of TEs during global demethylation in mammals. Generation of 83 
Dicer as well as Ago2 conditional and constitutive knockout ESC lines in the background of a 84 
Dnmt1 conditional knockout (cKO) line allowed us to define an ‘immediate’ endosiRNA 85 
dependent repressive response to TE activation and a subsequent ‘chronic’ response, 86 
characterised by targeting of repressive histone modifications, to global demethylation.  87 
88 
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Results  89 
Acute Dnmt1 deletion leads to TE demethylation in ESCs 90 
Our experimental system recapitulates epigenetic reprogramming of early embryos and 91 
PGCs in vitro. We used Cre mediated conditional Dnmt1 deletion in ESCs (Dnmt1 cKO) 92 
(Sharif et al., 2016) and sampled DNA and RNA at several defined time points after Dnmt1 93 
deletion for methylome, long and small transcriptome, as well as chromatin analyses (Figure 94 
1A). 95 
 96 
By whole genome bisulfite sequencing (WGBS-seq), we confirmed that acute deletion of 97 
Dnmt1 led to genome-wide demethylation from an initial 85% CpG methylation to 35% at day 98 
3 after deletion, and 20% at day 6 after deletion with no further demethylation thereafter 99 
(Figure 1B, S1A). The residual methylation can be attributed to the activity of the de novo 100 
DNA methyltransferases (Lei et al., 1996). Upon Dnmt1 cKO loss of methylation was in genic 101 
and intergenic elements, CGIs as well as non-CGI promoters (Fig 1B). Characteristic 102 
methylation profiles over gene bodies were reduced with the same kinetics as the rest of the 103 
genome upon Dnmt1 cKO (Figure S1B). Furthermore, low methylated regions (LMRs) and 104 
active enhancers became demethylated (Fig S1C). Thus, this in vitro model results in 105 
replication dependent global demethylation of the genome, which closely resembles the 106 
dynamics of global reprogramming in early embryos and PGCs (von Meyenn et al., 2016). 107 
 108 
To analyse TEs in WGBS-seq, RNA-seq and ChIP-seq data, we only considered uniquely 109 
mapped reads and filtered out TEs overlapping the (+/- 2 kb) region surrounding genes. 110 
While unique mapping might not capture all information about young TEs (as they lack the 111 
increased sequence divergence of older TEs which makes unique mapping more efficient; 112 
Lerat et al., 2003), this conservative approach allows us to be confident that mapped reads 113 
can be definitively ascribed to specific TE subfamilies. Moreover, the filtering of the region 114 
(+/- 2 kb) surrounding genes avoids ambiguity about the origin of TE expression from 115 
promoters which are not their own (Figure S1D, Data S1).  116 
 117 
Acute Dnmt1 deletion led to hypomethylation of TEs at the same rate as the rest of the 118 
genome (Figure 1B, S1E) with the exception of IAPs, RLTRs and MMERVK10C, which 119 
preserved higher methylation levels (Figure S1F). Thus our experimental system also closely 120 
recapitulates global demethylation dynamics of TEs in vivo, including the fact that IAPs are 121 
relatively resistant to global demethylation (Seisenberger et al., 2012, Kobayashi et al., 122 
2013). 123 
 124 
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Increased sense transcription of TEs upon hypomethylation combines with pervasive 125 
antisense transcription 126 
Next, we performed total RNA sequencing (RNA-seq) upon acute Dnmt1 deletion to examine 127 
if demethylation led to transcriptional activation of TEs. Transcriptional activation was limited 128 
to specific classes of ERVs (Figure 1C). We found TEs with increased transcription upon 129 
hypomethylation that remained active over the whole time-course (MMERVK10C) as well as 130 
TEs initially activated but notably subsequently re-silenced (e.g. IAPs and MERVLs). 131 
 132 
In addition to TEs, a small number of genes became activated upon loss of DNA methylation 133 
(Figure S1G, H), including the imprinted genes Xlr3a, Mirg and Rian (Table S1), consistent 134 
with the known roles for methylation in regulation of these genes (Ferguson-Smith, 2011) 135 
(Figure S1I). DNA hypomethylation did not result in ESC differentiation, as indicated by the 136 
unaltered expression of the core pluripotency network (Figure S1J). 137 
 138 
Interestingly, when quantifying reads overlapping with genes we found upon global 139 
hypomethylation increased pervasive transcription in the antisense orientation to those 140 
genes (Figure 1D). These pervasive antisense transcripts are in fact produced by 141 
transcription of TEs that have integrated in an antisense orientation to the genes (Figure 1E). 142 
Consistent with previous studies, high numbers of TEs were found to be preferentially 143 
integrated in antisense orientation to genes (van de Lagemaat et al., 2006) (Figure S1K). 144 
 145 
We next analysed the total RNA-seq data to determine whether both sense and antisense 146 
transcription was detectable at sites of TE integration. Indeed, TE antisense transcription 147 
was found in all TE families, with sense transcripts of members of the ERVs being 148 
upregulated consistent with their activation in response to demethylation (Figure 1F). We 149 
also included TEs which were not activated by hypomethylation, but instead are regulated in 150 
a DICER dependent manner (see Figure 3E). 151 
 152 
Sense/antisense transcription of TEs correlates with AGO2 bound endosiRNAs 153 
The production of sense and antisense transcripts across TEs is expected to lead to 154 
dsRNAs, which can subsequently induce an RNAi response and silence TEs post-155 
transcriptionally. These results suggest that TE expression may be sensed by pervasive 156 
antisense transcription, thus constituting a TE ‘trap’ (Figure 2A). To test this hypothesis, we 157 
performed small RNA-seq at defined time-points after Dnmt1 deletion. The majority of small 158 
RNAs were miRNAs (Figure S2A-C) and were expressed independently of DNA methylation, 159 
with the exception of miRNAs from the imprinted Dlk and Xlr3 loci (Figure S2D, E). Small 160 
RNA quantitative real-time PCR (RT-qPCR) of mature miRNAs confirmed their methylation 161 
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dependent regulation (Figure S2F). The Dlk locus serves as an example of the genome-wide 162 
response to acute Dnmt1 deletion with the imprint control region (ICR) becoming 163 
demethylated leading to transcriptional upregulation of the imprinted locus and embedded 164 
miRNAs (Figure S2G).  165 
 166 
Due to the short reads in small RNA-seq, we used TE consensus sequence mapping to 167 
analyse global TE derived small RNAs. This method allows unambiguous alignment to 168 
unique TE classes. Notably, we observed a substantial increase of small RNAs mapping to 169 
IAP, MERVL and ETn upon Dnmt1 deletion (Figure 2B), which in the case of IAPs mapped 170 
across the whole length of the element (Figure 2C). Small RNAs mapping to L1MdGf and 171 
MMERVK10C, respectively, were detected both in wild type (WT) and Dnmt1 cKO ESCs 172 
(Figure 2B). 173 
 174 
The mammalian ARGONAUTE proteins (AGO) are  critical components of the RNA induced 175 
silencing complex (RISC). AGO2 can bind miRNAs as well as endogenous siRNAs 176 
(endosiRNAs) and has the ability to “slice” its targets (Doi et al., 2003). We performed AGO2 177 
immunoprecipitation (IP) from Dnmt1 cKO ESC at day 9 after deletion and analysed the 178 
pulldown by small RNA-seq (Figure 2D). The AGO2-IP small RNA-seq libraries of both WT 179 
and Dnmt1 cKO ESCs were composed to 90% of known miRNAs, while 40% of the 180 
remaining small RNAs mapped to TEs (Figure S2H, only Dnmt1 cKO shown). This subset of 181 
AGO2 bound small RNAs was 22 nucleotides (nts) long and mapped to sense and antisense 182 
strands of TEs (Figure 2E); the small RNAs had 5’ U-overhangs (Figure S2I) and formed 183 
characteristic 5’-5’ overlaps at nt 20, identifying them as bona fide endosiRNAs (Figure S2J) 184 
(Ghildiyal and Zamore, 2009). AGO2 bound endosiRNAs mapping to MERVL and RLTR45 185 
were expressed throughout the time-course while endosiRNAs mapping to L1, IAP and ETn 186 
or MMERVK10C were significantly enriched upon Dnmt1 deletion (Figure 2F), suggesting 187 
that functional endosiRNAs against specific TE classes are generated during global 188 
demethylation.  189 
 190 
We also generated small RNA-seq libraries of E13.5 and E14.5 male and female PGCs and 191 
found that ~10% of all 20-24 nt small RNAs mapped to TEs in both male and female E13.5 192 
and E14.5 PGCs with small RNAs mapping to IAPEZ and L1MdGf particularly enriched in 193 
E14.5 PGCs (Figure S2K-L). These small RNAs had the defining properties of endosiRNAs 194 
(Figure S2M-O), suggesting that a similar response to the one we have discovered in ESCs 195 
also exists during global demethylation in the germ line in vivo.  196 
 197 
Key RNAi components are involved in the repression of specific TE classes 198 
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To investigate whether the observed endosiRNAs were involved in restraining TE 199 
expression, we knocked down key components of the endosiRNA and miRNA pathways in 200 
Dnmt1 cKO and monitored IAP expression by RT-qPCR. Upon knockdown of Dicer or Ago2, 201 
both essential components of the RNAi pathway, IAP transcription was strongly upregulated, 202 
while knockdown of Dgcr8 (dispensable for endosiRNA function) had no effect on IAP 203 
expression (Figure 3A). This suggests that TEs are controlled by functional endosiRNAs. 204 
 205 
To examine the role of the RNAi pathway during global hypomethylation in more detail we 206 
generated conditional Dicer/Dnmt1 cDKO ESCs (Figure S3A), and carried out a number of 207 
quality controls. Loss of Dicer activity was confirmed by loss of expression of mmu-miR-93, 208 
while Dicer independent small nucleolar RNAs (snoRNAs) were still expressed (Figure S3A). 209 
We generated total RNA-seq data from Dicer/Dnmt1 cDKO ESCs and found increased 210 
antisense transcripts in these cells, as seen earlier in the Dnmt1 cKO ESCs (Figure S3B). 211 
Furthermore, small RNA-seq of Dicer/Dnmt1 cDKO ESCs showed a depletion of all miRNAs 212 
(Figure S3C) and a loss of 21-24nt small RNAs mapping to all TEs as well as specifically to 213 
L1MdGf and IAPEz (Figure 3B, S3D), which proves that the described small RNAs are 214 
DICER dependent products. 215 
 216 
Acute conditional deletion of both Dicer and Dnmt1 together resulted in significantly higher 217 
levels of transcription of IAPs by day 10 in comparison to those in Dnmt1 cKO ESCs (Figure 218 
3C). Importantly, there was no notable resilencing of IAP transcripts in Dicer/Dnmt1 cDKO. 219 
This demonstrates that DICER plays a role in the re-repression of IAPs upon global 220 
hypomethylation. LINEs and major satellites (non-TE pericentric repeats), whilst not 221 
upregulated upon Dnmt1 deletion, were also dramatically upregulated following Dicer 222 
deletion (Figure 3C). Dicer/Dnmt1 cDKO ESCs started to show signs of cell death from day 223 
12 after deletion, potentially as a result of TE mobilisation, as has been shown in constitutive 224 
Dicer KO (Bodak et al., 2017).  225 
 226 
We next asked whether deletion of RNAi components downstream of DICER would lead to a 227 
similar response and generated conditional Ago2/Dnmt1 cDKO ESCs (Figure S4G). While 228 
we initially expected that Ago2/Dnmt1 cDKO might show comparable results to the 229 
Dicer/Dnmt1 cDKO, we found that the deletion kinetics of Ago2 KO in their respective ESC 230 
lines were substantially slower (Figure S3E-G). Surprisingly however, we found that 231 
transcriptional upregulation of TEs in the Ago2/Dnmt1 cDKO was considerably blunted 232 
(Figure 3D).  233 
 234 
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To gain deeper insights into the blunted TE expression, we constitutively deleted Ago2 or 235 
Dicer using CRISPR/Cas9 genome editing in the background of Dnmt1 cKO ESCs (Figure 236 
S5H-J). We first determined the effect of Dicer KO on genic and transposon transcription and 237 
were able to identify TEs that were solely dependent on DICER for their silencing, such as 238 
L1MdGf (Figure 3E, S3K-O).  239 
 240 
We next performed a time-course of Dnmt1 deletion in Ago2 KO/Dnmt1 cKO and in Dicer 241 
KO/Dnmt1 cKO and measured IAP expression by RT-qPCR. Notably, we found substantially 242 
attenuated upregulation of IAPs upon Dnmt1 deletion in both ESC lines, which was 243 
confirmed by total RNA-seq (Figure 3D, S3O). These results indicate that in addition to DNA 244 
methylation and RNAi, alternative TE silencing mechanisms can be recruited. While DICER 245 
dependent mechanisms restrict the expression of specific TE classes upon deletion of 246 
Dnmt1, ablation of the RNAi pathway prior to demethylation triggers the engagement of 247 
another silencing mechanism. Since repressive histone marks have been shown to 248 
contribute to TE repression in somatic tissues and in ESCs (Karimi et al., 2011, Maksakova 249 
et al., 2006) we asked whether these might constitute the additional repressive mechanism 250 
observed here. 251 
 252 
TE silencing by repressive histone marks 253 
To study the involvement of chromatin in TE regulation upon global hypomethylation, we 254 
carried out ChIP-seq analyses of the repressive histone marks H3K9me2, H3K9me3 and 255 
H3K27me3 at 4 and 8 days after deletion of Dnmt1, i.e. before and after transcriptional 256 
upregulation of the relevant TE classes. Genome-wide distribution of the repressive histone 257 
marks - H3K27me3, H3K9me2 and H3K9me3 - confirmed earlier studies (Iurlaro et al., 2017, 258 
Tang et al., 2016) with H3K27me3 enrichment in gene bodies and H3K9me2/3 enrichment in 259 
TEs (Figure S4A). Additionally, H3K27me3 was enriched in promoter regions but depleted at 260 
transcription start sites (TSS) (Figure S4B,C). Upon Dnmt1 deletion neither of these 261 
repressive histone marks were redistributed genome-wide (Figure S4D).  262 
 263 
However, DICER-independent MERVLs showed increased H3K27me3 deposition upon 264 
Dnmt1 deletion, recapitulating what has been reported in naïve hypomethylated ESCs 265 
(Walter et al., 2016) (Figure 4A). We found H3K9me3 enrichment across IAPs independent 266 
of DNA methylation levels, confirming previous results (Figure S4E,F) (Walter et al., 2016, 267 
Sharif et al., 2016). Importantly, H3K27me3 and H3K9me2 deposition was found on IAPs 9 268 
days after Dnmt1 deletion, explaining why early, but not late, depletion of Dicer or Ago2 269 
result in sustained TE expression. These results show that two repressive pathways are in 270 
place to control TE expression in ESCs (Figure S4I), and, importantly, that they are 271 
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staggered in time, with an immediate RNAi response and a subsequent chronic chromatin 272 
response.  273 
 274 
To obtain insights into the attenuated IAP expression in Dicer KO/Dnmt1 cKO, we performed 275 
ChIP-seq of the same repressive histone marks. While we did not observe a genome-wide 276 
redistribution of H3K27me3, H3K9me2 and H3K9me3 in the Dicer KO nor the Dicer 277 
KO/Dnmt1 cKO (Figure S4G,H), we observed a clear redistribution of repressive histone 278 
marks over TEs in Dicer KO and in particular an enrichment of H3K27me3 and of H3K9me2 279 
at IAPs. This was even further increased upon Dnmt1 deletion (Figure 4B). Hence, acute 280 
depletion of DICER during global demethylation abrogates re-silencing of IAPs whilst 281 
constitutive deletion of Dicer instigates a repressive chromatin response in IAPs which 282 
suppresses reactivation upon hypomethylation (Figure 4C). 283 
284 
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Discussion 285 
How TEs are controlled during global epigenetic reprogramming in the mammalian germline 286 
is a highly relevant question. The present study provides to our knowledge the first evidence 287 
of AGO2 bound endosiRNAs in ESCs during global DNA hypomethylation, which restrict TE 288 
expression as judged by acute depletion of Dicer or Ago2. That we also detect DICER-289 
dependent endosiRNAs in PGCs indicates that it is likely that the described mechanism also 290 
operates in vivo. This mechanism constitutes a first line of TE defence during epigenetic 291 
reprogramming. A second line of defence is provided by chromatin targeting and retargeting, 292 
presumably through the evolution of sequence specific recognition modules of TEs such as 293 
zinc finger proteins (Rowe and Trono, 2011). Our work also indicates a link between these 294 
systems; they are staggered in time and thus potentially connected.  295 
 296 
Many TE families are associated with transcribed genes or lncRNAs in ESCs (Kelley and 297 
Rinn, 2012). This provides the potential for sense/antisense transcription to occur when TEs 298 
become demethylated, as observed here (Figure 1F). In oocytes, pseudogenes provide the 299 
antisense strand to TEs to feed into an RNAi pathway (Tam et al., 2008) and TEs have been 300 
shown to give rise to dsRNA in preimplantation embryos due to their bidirectional promoters 301 
(Svoboda et al., 2004). Indeed, we found intragenic active TEs preferentially integrated in 302 
antisense direction to the gene (Figure S1K). Previous studies had concluded that this could 303 
prevent disruption of normal gene expression (van de Lagemaat et al., 2006). We suggest an 304 
additional reason why this direction of insertion is evolutionarily favoured: it produces a 305 
trapping system (‘trap’) for transposon activation during epigenetic reprogramming, in order 306 
to tame newly invading TEs (Fig 2A). 307 
 308 
Overlapping sense/antisense transcription feeds into an endosiRNA pathway regulated by 309 
DICER and AGO2 to silence TEs. The generation of the two constitutive and conditional KO 310 
ESCs in the background of the Dnmt1 cKO allowed us to dissect the dynamics of TE control 311 
during global hypomethylation, revealing an ‘immediate’ response which is characterised by 312 
endosiRNAs and affected by acute depletion of Dicer or Ago2. This is followed by a ‘chronic’ 313 
response which is defined by targeting of repressive histone modifications (particularly 314 
H3K27me3 and H3K9me2) and occurs subsequent to the endosiRNA response in Dnmt1 315 
cKO and Dnmt1/Dicer cDKO ESCs (Figure 4C). Intriguingly, non-acute depletion of Dicer 316 
also instigates deposition of H3K27me3 and H3K9me2 independent of DNA demethylation, 317 
suggesting that the two systems are linked. We suggest a mechanism of TE control by which 318 
the ‘immediate’ endosiRNA response to global methylation erasure is followed by a ‘chronic’ 319 
repressive chromatin response. Interestingly, the ‘chronic’ response is initiated by deletion of 320 
Dnmt1 as well as by abrogation of the ‘immediate’ defence. Therefore, the ‘immediate’ and 321 
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‘chronic' responses are not only staggered in time but also appear mechanistically linked. 322 
Unravelling the molecular underpinnings of this link will be an important topic of future work.  323 
 324 
The specific response of IAPs and LINEs to loss of DICER may be explained by the fact that 325 
they embody the most active retrotransposition competent TE copies in the mouse germline 326 
(Maksakova et al., 2006) and are primarily guarded by endosiRNAs, with chromatin playing a 327 
secondary role in their transcriptional restriction. Other TEs by contrast are primarily 328 
controlled by chromatin redistribution upon global demethylation. The present study 329 
highlights the exquisite variety and interplay of epigenetic modifications by which the 330 
transcription of different TE families is regulated. Future work in this area, particularly with 331 
high coverage long read sequencing, will hopefully allow the characterisation of 332 
transcriptional and epigenetic regulation of individual TE copies in the genome. 333 
 334 
We identified DICER as an important factor in small RNA dependent silencing of TEs. 335 
Nonetheless, DICER-independent AGO2-bound small RNAs may also play a role in TE 336 
silencing (Babiarz et al., 2008, Murchison et al., 2005). DICER-independent small RNAs 337 
might also explain the repression of ETns, to which increasing amounts of AGO2-bound 338 
small RNAs mapped, but which were not responsive to Dicer KO.  339 
 340 
TEs benefit from transcriptional activation in the germ line but not in somatic cells (Haig, 341 
2016). Hence one might speculate that they may regulate aspects of epigenetic 342 
reprogramming in germ cells to their benefit. In this respect TEs may not be the sole 343 
benefactors of their own mobilisation but it also impacts on creating novelty in the host 344 
genome. Nevertheless unrestrained activation and transposition would presumably be 345 
detrimental to the host genome, and hence a sophisticated balance of regulatory 346 
mechanisms for TEs has evolved in the germ line, including the chromatin retargeting and 347 
the endosiRNA pathway we report here.  348 
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Figure Legends 506 
Figure 1: Transcriptional upregulation of specific TE classes upon acute Dnmt1 deletion 507 
(A) (left) Schematic overview of epigenetic reprogramming during preimplantation and male 508 
(blue) and female (red) germline development. (right) Schematic of Dnmt1 cKO as an in vitro 509 
system for mechanistic study of TE regulation during epigenetic reprogramming.  510 
(B) Violin plots showing the distribution of CpG methylation levels measured by WGBS-seq 511 
of WT (grey) and conditional Dnmt1 cKO ESC induced for days depicted in the figure. The 512 
percentage of methylated cytosines was quantified in consecutive 50 CpG windows genome-513 
wide. CGI = CpG Island. For significance analysis Wilcoxon rank sum test with Bonferroni 514 
correction testing with a p-value threshold of < 0.05. 515 
(C) Heatmap of unbiased hierarchical clustering of all TEs responsive to Dnmt1 cKO across 516 
the time-course of KO induction. It shows relative expression (z-score) of TEs upon Dnmt1 517 
cKO, n=2. 518 
(D) Bar graph showing percentage of genic antisense transcription upon Dnmt1 deletion in 519 
KO relative to WT samples, n=2. 520 
(E) Chromosome view of TE inserted antisense to gene. Position of TE is denoted (top 521 
panel) along with sense strand specific RNA-seq reads (lower panels, sense transcription 522 
shown in blue, antisense transcription shown in red). Each read is depicted. Arrows indicate 523 
directionality of reads.  524 
(F) Sense/Antisense expression of TEs as determined by RNA-seq analysis of conditional 525 
Dnmt1 cKO ESC uninduced (black), induced for days depicted in figure. Crosshatched bars 526 
depict antisense reads. The figure shows mean of n=2.  527 
See also Figure S2, S4I, Data S1. 528 
 529 
Figure 2: Small RNAs are being produced from TEs upon loss of Dnmt1 530 
(A) Schematic displaying the hypothesis model of pervasive transcription overlapping TEs 531 
acting as a trap of transcriptional activation of TEs. This could work through the production of 532 
dsRNAs from sense and antisense transcripts that feed into the RNAi pathway which 533 
subsequently silences the TEs. 534 
(B) Small RNA-seq mapped to different classes of TEs of WT (grey) and conditional Dnmt1 535 
cKO ESC induced for days depiced in figure. *p<0.05, ** p<0.005, two-tailed student t-test. 536 
Bars represent mean +/- SD, n=3. All reads of a size between 20-24 nt have been mapped to 537 
TE consensus sequence. 538 
(C) Small RNA-seq mapped to consensus sequence of IAPEZ. All reads of a size between 539 
20-36 nt have been mapped to the IAPEZ consensus sequence. 540 
(D) Schematic displaying AGO2 IP of small RNAs.  541 
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(E) Size distribution of AGO2 bound small RNAs after AGO2 IP of sense (black) and 542 
antisense (grey) small RNAs mapping to repeatmasker consensus sequences using the 543 
piPipes small RNA-seq pipeline (Han et al., 2014).  544 
(F) Small RNA-seq of AGO2 bound small RNAs mapped to TE classes of WT (grey) and 545 
conditional Dnmt1 cKO ESC induced for 9 days (light blue). *p<0.05, **p<0.005, two-tailed 546 
student t-test. Bars represent mean +/- SD, n=4.  547 
See also Figure S2, S4I, Data S1. 548 
 549 
Figure 3: TEs are repressed by a DICER mechanism 550 
(A) Knockdown (KD) of RNAi players (upper left) Schematic of siRNA KD in Dnmt1 cKO 551 
ESCs: the genome gets demethylated (orange), IAPs get transcriptionally activated and 552 
resilenced (red) if small RNAs are present (grey), however KD of the RNAi pathway will 553 
deplete small RNAs, (lower left) RT-qPCR analysis showing KD efficiencies of Dicer, Ago2 554 
and Dgcr8 upon treatment with siRNAs. (right) Expression of IAPs upon Dicer, Ago2, Dgcr8 555 
or non-targeting siRNA transfection. The data is normalised to non-targeting control. Bars 556 
represent mean +/- SD, n=3. *p<0.05, **p<0.005, two-tailed student t-test.  557 
(B) Small RNA-seq of Dicer/Dnmt1 cDKO and Dnmt1 cKO ESCs. Sense (orange), antisense 558 
(blue) small RNAs are separated by size and were mapped to all TEs. Reads were 559 
normalised to non-induced WT (Dicer fl/fl /Dnmt1 fl/fl) ESCs, n=1. 560 
(C) RT-qPCR analysis of TE classes in ESCs following conditional Dnmt1 cKO, Dnmt1/Dicer 561 
cDKO by treatment with 4OHT or Dicer KO. Bars represent mean of 2 biological replicates 562 
with 2 technical replicates. Values were normalized to Atp5b, Hspcb and major satellites 563 
were normalised to U1. *p<0.05, **p<0.005, two-tailed student t-test.  564 
(D) RT-qPCR analysis of IAPEz in the indicated ESC lines. Conditional deletions were 565 
induced by treatment with 4OHT for the indicated days. Values were normalized to Atp5b 566 
and Hspcb and are relative to the respective WT sample for each KO line, indicated by 567 
dashed line. Error bars represent mean +/- SD, n=3 for Dnmt1 cKO, Dicer KO/Dnmt1 cKO 568 
and Ago2 KO/Dnmt1 cKO and n=2 for Dicer/Dnmt1 cDKO, Ago2/Dnmt1 cDKO. Ago2 569 
KO/Dnmt1 cKO time points day 9 and 11 were not collected.  570 
(E) Heatmap of unbiased hierarchical clustering of all TE classes responsive to Dicer KO.  571 
Heatmaps depicts relative expression (z-score) of TEs upon Dicer KO, n=1. 572 
See also Figure S4, S5, Table S2, S4I. 573 
 574 
Figure 4: Repressive Histone modifications enriched at TEs upon global demethylation 575 
(A) Heatmap showing relative enrichment (z-score) of repressive Histone marks (H3K9me3, 576 
H3K27me3 and H3K9me2) at TE classes differentially regulated upon both Dicer KO (Figure 577 
3A) and Dnmt1 cKO (Figure 1C) and normalised to enrichment in WT ESCs.  578 
- 19 - 
(B)  H3K27me3, H3K9me3 and H3K9me2 enrichment over TEs dependent on Dicer and 579 
Dnmt1. Heatmap depicts ChIP-seq data of H3K27me3 mapped to TE families at depicted 580 
days after Dnmt1 cKO, Dicer KO and Dnmt1/Dicer cDKO in comparison to WT ESCs.  581 
(C) Schematic of the two levels of TE control upon global demethylation. Upon deletion of 582 
Dnmt1, DNA methylation (5mC; orange) mediated repression is lost, and transposon 583 
expression increases (as an example IAP expression is shown in green). Subsequently small 584 
RNAs (red; ‘immediate’ response) and repressive histone marks (chromatin, blue; ‘chronic’ 585 
response) establish a new repressive environment. Also indicated are the time-points at 586 
which the different experimental manipulations interfere with the system. 587 
See also Figure S4, Data S1. 588 
 589 
Supplemental Information 590 
Supplemental Information includes Supplemental Experimental Procedures, four figures, 591 
three tables and one data file. 592 
593 
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STAR Methods 594 
CONTACT FOR REAGENT AND RESOURCE SHARING 595 
Further information and requests for resources and reagents should be directed to and will 596 
be fulfilled by the Lead Contact, Rebecca Berrens (rebecca.berrens@gmail.com). The Ago2 597 
antibody for was obtained from EMBL, after establishing an MTA with the laboratory of Prof. 598 
Donal O’Carroll at University of Edinburgh. 599 
 600 
EXPERIMENTAL MODEL AND SUBJECT DETAILS 601 
Cell lines 602 
Mouse embryonic stem cell (ESC) lines were used in this study. Dnmt1loxP/loxP ESCs (strain 603 
C57BL/6) were obtained from Haruhiko Koseki, RIKEN Center for Integrative Medical 604 
Sciences, Yokohama City, Japan (Sharif et al., 2016). Dicer/Dnmt1 cDKO, Ago2/Dnmt1 605 
cDKO, Dicer KO and Ago2 KO ESC lines were generated using Dnmt1loxP/loxP ESCs using the 606 
CRISPR/Cas9 targeting and screening primers mentioned in Table S3. 607 
 608 
Mice 609 
All in vivo PGC samples were collected from timed mattings of C57Bl/6J female mice 610 
carrying the Oct4-GFP transgene expressed in the developing gonad (Yoshimizu et al., 611 
1999). Primordial germ cells from male and female embryos at E13.5 and E14.5 were 612 
collected. All procedures were covered by a project license (to WR) under the Animal 613 
(Scientific Procedures) Act 1986, and is locally regulated by the Babraham Institute Animal 614 
Welfare, Experimentation, and Ethics Committee. 615 
 616 
 617 
METHOD DETAILS 618 
DNA/RNA Extraction 619 
Genomic DNA was prepared using QIAmp DNA Micro Kit (QIAGEN). RNA was extracted 620 
using TriReagent (Sigma) and Phase Lock tubes (5Prime) following manufacturers’ 621 
instructions and subjected to DNAse treatment using the DNA-free kit (Ambion DNA-free 622 
DNA Cat #1311027) according to the manufacturers’ instructions.  623 
 624 
Small RNA RT-qPCR 625 
For small RNA qPCR Taqman miRNA kits were used according to the manufacturer's’ 626 
instructions for mmu_miR93 (Taqman, Cat. No. TM001090), mmu_miR7081_mat (Taqman, 627 
Cat. No. TM467052_mat) and snoRNA202 (Taqman, Cat. No. 001232) was used as a 628 
positive control. RT-qPCR primers are listed in Table S2.  629 
 630 
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AGO2 IP 631 
ESCs were cultured on 15 cm dishes and harvested in 1 x PBS. Pellets were frozen at -80°C 632 
until further processing. ESC were resuspended in 300 µl Lysis buffer (50 mM Tris, pH8, 633 
150 mM NaCl, 5 mM MgCl2, 15 % Glycerol, 1 mM DTT, 0.5% Sodium deoxycholate, 634 
0.5% Triton X-100, Protease inhibitor cocktail (Roche), 50µg/ml yeast tRNA, 2mM Vanadyl 635 
ribonucleoside complex) and cells were pelleted at 10,000 rpm, 10 min, 4°C. The 636 
supernatant was used as whole ESC extract. 25 µL beads (protein G Sepharose) were 637 
washed 3 times with 1 mL of Wash Buffer (10 mM Tris pH 8, 150 mM NaCl, 1 mM MgCl2, 638 
0,01% NP-40). 50 µl of purified AGO2 antibody (O’Carroll lab) was added, filled up to 1mL 639 
with Wash Buffer and incubated O/N at 4°C in a rotating wheel. On the next day, the beads 640 
were washed 3 times with Wash Buffer and the negative control (beads with extract but 641 
without serum) was prepared. The ESC extract was pre-spun to remove precipitated proteins 642 
and 200µL extract was added to the beads and filled up to 600µL with Lysis buffer. The mix 643 
was incubated for 2-4h at 4°C in a rotating wheel and subsequently washed 5 times with 644 
wash buffer and the IP was eluted with 300µL Proteinase K buffer (10 mM Tris pH 7,5, 0,5% 645 
SDS, 5 mM EDTA, 1 µL Proteinase K/reaction) after 30 min for 50°C incubation on the 646 
thermomixer, at 850 rpm. RNA was isolated by phenol extraction and eluted in 8 µl H2O. 647 
 648 
RNAi knockdown of Ago2, Dicer1, Dgcr8 in Dnmt1fl/fl ES cells  649 
RNA interference experiments were performed according to manufacturers’ instructions with 650 
modifications. Transfections of Dharmacon siGENOME SMARTpool siRNA against mouse 651 
Dicer (Dharmacon, Cat. No. MU-040892-01-0005), Dgcr8 (Dharmacon, Cat. No. MU-652 
051365-00-0002) or Ago2 (Dharmacon, Cat. No. MU-058989-01-0005) and siGENOME non-653 
targeting siRNA#2 (Dharmacon, Cat. No. D-001210-02-05) were performed with 654 
Lipofectamine 2000 according to the manufacturers’ instructions. The transfection was done 655 
in two rounds. The cells were plated at a density of 1 x 10^5 ES cells per well of gelatinized 656 
12-well plate. One day later the first transfection was done the following for each well of a 12 657 
well plate: 50uM siRNA were added to 100 ul DMEM. 6 ul of Lipofectamin2000 were mixed 658 
with 100 ul DMEM. The mix was incubated for 5 min at room temperature. Afterwards the 659 
two solutions were mixed and incubated at room temperature for 15 min. 200 ul of the siRNA 660 
and Lipofectamin2000 mix were added to each well of a 12 well plate. On the third day the 661 
medium was changed. On the fourth day the second transfection was done the following: 662 
125uM siRNA were added to 250 ul DMEM. 7.5 ul of Lipofectamin2000 were added to 250 ul 663 
DMEM and incubated at room temperature for 5 min. The solutions were then mixed and 664 
again incubated for 15 min at room temperature. The cells were washed with PBS, 665 
trypsinised, inactivated and resuspended in ESC medium and plated on a gelatinised 6-well 666 
plate I a total volume of 1.8 ml each well. 500ul of siRNA and Lipofectamin2000 were added 667 
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to each well. The ESCs were incubated at 37C for 6 hours and then the medium was 668 
changed.  669 
Cells were harvested 48 h after the 2nd transfection and RNA was extracted and analysed. 670 
 671 
RT-qPCR 672 
100 ng -1 µg of DNAse treated RNA was reverse transcribed (Thermo RevertAid #K1622) 673 
using random hexamer primers. Endogenous controls (Atp5b, Hspcb, U1) were used to 674 
normalise expression. Major satellite RT-qPCR was done as previously described (Lehnertz 675 
et al., 2003, Probst et al., 2010). Primers are listed in Table S2. 676 
 677 
CRISPR cKO and KO 678 
guideRNAs (gRNAs) were constructed following https://chopchop.rc.fas.harvard.edu/  and 679 
http://crispr.mit.edu/ and cloned following the protocol by (Ran et al., 2013) into 680 
pSpCas9(BB)-2A-GFP (Addgene plasmid ID: 48138) or pSpCas9(BB)-2A-hCD4, constructed 681 
by replacing the GFP in the pSpCas9(BB)-2A-GFP with human CD4. Cells were cultured on 682 
feeder plates and transfected with 1 µg gRNA and 100 ng donor DNA, where appropriate, 683 
using Lipofectamine 2000 transfection reagent. Cells were sorted for GFP in single cell 684 
colonies into 96 well plates using flow cytometry or CD4 expression plating on 10cm dishes 685 
as single cell colonies. Colonies were screened by PCR using MyTaq (Bioline, BIO-25044) 686 
and Sanger sequencing. See Figure S4A, S4D, S5A, S5D for knock out strategy and Table 687 
S2 for gRNAs, screening primers and donor DNA sequence.  688 
 689 
Fluorescence-activated cell sorting (FACS) 690 
Cells were trypsinised and resuspended in PBS + 1% FBS and analysed on a LSR Fortessa 691 
Cell Analyzer (BD). Cells were gated for singlets and living cells were identified using the 692 
level of DAPI incorporation and the level of GFP signal was recorded for each cell.  693 
 694 
CD4 pull down 695 
Cells were trypsinised and resuspended in 70 µl 1 x PBS and stained with human CD4 696 
Microbead antibody (Miltenyl Biotec, Cat. No. 130-045-101) according to manufacturers’ 697 
instructions. The CD4 positive cells were enriched using MACS columns. Negative cells were 698 
collected from flow through. The cells were eluted in 500 µl 1 x PBS.  699 
 700 
In vivo PGC collection 701 
All embryonic samples for library preparation were collected from timed mattings of C57Bl/6J 702 
female mice PGCs that express the Oct4-GFP transgene in the developing gonad 703 
(Yoshimizu et al., 1999). E13.5 and E14.5 PGCs, male and female samples were collected 704 
- 23 - 
separately and after collagenase digestion PGC samples were sorted for GFP positive cells 705 
using a FACSAria (BD) cell sorter with >98% purity.  706 
 707 
Cell lines and culture conditions 708 
Mouse ESCs were cultured with or without feeders on gelatinized plates (0.1% gelatin) in 709 
serum-containing media (DMEM 4,500 mg/l glucose, 4 mM L-glutamine, 15% fetal bovine 710 
serum, 1 U/ml penicillin, 1 μg/ml streptomycin, 0.1 mM nonessential amino acids, 50 μM β-711 
mercaptoethanol) supplemented with mouse LIF at 37°C and 5% CO2. Conditional deletion 712 
was induced by Cre mediated recombination, as described before (Sharif et al., 2016). Cre 713 
expression was induced in response to tamoxifen (4OHT, 800 nM). 714 
 715 
WGBS-seq libraries 716 
For preparation of WGBS-seq libraries, genomic DNA was sonicated using a Covaris 717 
Sonicator, followed by end-repair, A-tailing and methylated adapter (Illumina) ligation using 718 
NEBNext reagents (E6040S, NEB). Afterwards the libraries were bisulfite treated using 719 
Imprint DNA modification kit (MOD50-1KT, Sigma), followed by library amplification with 720 
indexed primers using KAPA HiFi Uracil HotStart DNA Polymerase (KAPA HiFi Uracil+, 721 
KK2801/2). Subsequently, the amplified libraries were purified and assessed for quality and 722 
quantity using High-Sensitivity DNA chips on an Agilent Bioanalyzer. High-throughput 723 
sequencing of all libraries was carried out with a 75 bp or 50 bp paired-end (PE) sequencing 724 
on Illumina HiSeq 2500 instruments using TruSeq reagents (Illumina, San Diego, CA, USA), 725 
according to manufacturers’ instructions. 726 
 727 
ChIP-seq libraries 728 
ESCs were grown on 15 cm dishes coated with 0.1 % gelatine until they were 80 % 729 
confluent. Subsequently cells were cross-linked with 1 % methanol-free formaldehyde in 730 
fresh medium for 10 minutes. To quench the cross-linking, 0.2 M final concentration of 731 
glycine was added. ESCs were washed twice with ice cold 1 x PBS (137 mM NaCl, 2.7 mM 732 
KCl, 10 mM Na2HPO4, 2 mM KH2PO4 dissolved in 800 ml distilled H2O, pH was adjusted to 733 
7.4 with HCl) and harvested using a cell scraper. Cells were then pelleted by centrifugation at 734 
8,000 x g at 4 ◦C for 3 min. Pellets were resuspended in LB1 bu er (50 mM HEPES’ KOH, pH 735 
7.5; 140 mM NaCl; 1 mM EDTA; 10 % glycerol; 0.5 % NP-40; 0.25 % Triton X-100, protease 736 
inhibitors) for 10 minutes at 4°C, pelleted and resuspended in LB2 buffer (10 mM Tris/HCl, 737 
pH 8.0; 200 mM NaCl; 1 mM EDTA; 0.5 mM EGTA, protease inhibitors) for 10 minutes at 4 738 
◦C. Cells were pelleted and resuspended in LB3 bu er (10 mM Tris-HCl, pH 8; 100 mM NaCl; 739 
1 mM EDTA; 0.5 mM EGTA; 0.1% Na/Deoxycholate; 0.5% N-Lauroylsarcosine, protease 740 
inhibitors). Next the cells were sonicated using Misonix Sonicator 3000. Triton X-100 was 741 
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added to a final concentration of 1 % and the lysate was centrifuged at 20,000 x g for 10 min 742 
to pellet the debris. The bead-antibody complexes were prepared before adding the 743 
sonicated DNA. Protein G-coupled Dynabeads (Thermo Fisher Scienti c, Cat. No. 10003D) 744 
and the primary antibodies in PBS with 5 mg/ml BSA were incubated ON. Subsequently, the 745 
bead-antibody complexes were added to the sonicated chromatin and both were incubated 746 
at 4 ◦C ON. On the following day, beads were washed extensively with RIPA buffer (50 mM 747 
HEPES pH 7.6, 1 mM EDTA, 0.7 % Na deoxycholate, 1 % NP-40, 0.5M LiCl), once with 1x 748 
TE bu er (1 M Tris-HCl (pH approximately 8.0), 0.1 M EDTA) and eluted in 200 μl of buffer 749 
containing 1 % SDS and 0.1 M NaHCO3. They were then incubated at 65°C ON for reverse 750 
cross-linking. RNase A treatment at 37°C was carried out for 1 h, then Proteinase K 751 
treatment at 55°C for 2 h. The DNA was then extracted with phenol/chloroform, followed by 752 
ethanol precipitation. ChIP-seq library preparation was performed using MicroPlex Library 753 
Preparation kit (Diagenode) following manufacturer’s instructions. Libraries were quantified 754 
using the High Sensitivity DNA Bioanalyzer kit and Kapa library quantification. High-755 
throughput sequencing of all libraries was carried out with a 100 bp PE sequencing on 756 
Illumina HiSeq 2500 instruments. 757 
 758 
Small RNA-seq libraries 759 
Small RNA-seq libraries were produced according to the Illumina protocol (RS-200-0012), 760 
with the following changes: 10 ng or 1 μg RNA (RIN of 8-10) were used as input material. 761 
The instructions were followed until the cDNA purification. In order to purify the cDNA, the 762 
samples were run on 10 % Novex PAGE gel. The entire area between the 145 and 160 bp 763 
markers was excised, gel purified by addition of 0.3 M NaCl and the DNA was eluted from 764 
the gel by rotation over night at 4°C. The DNA was precipitated in EtOH overnight and the 765 
library was quantified using the HighSensitivity Bioanalyzer kit. The small RNA-seq libraries 766 
were additionally quantified by Kapa Library Quantification. The libraries were pooled 767 
according to their molecular weight. High-throughput sequencing of all libraries was carried 768 
out with a 50 bp SE on Miseq or SE and PE on Illumina HiSeq 2500 instruments. 769 
 770 
Total RNA-seq libraries 771 
Stranded Total RNAseq libraries were prepared according to manufacturers’ protocols using 772 
the Illumina stranded Total RNAseq library preparation after Ribo-zero depletion. High-773 
throughput sequencing of all libraries was carried out with a 100 bp PE on Illumina HiSeq 774 
2500 instruments. 775 
 776 
 777 
QUANTIFICATION AND STATISTICAL ANALYSIS 778 
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WGBS-seq mapping and analysis 779 
Raw sequence reads from WBGS libraries were trimmed to remove poor quality reads and 780 
adapter contamination, using Trim Galore (v0.4.1, 781 
http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/) with default parameters. The 782 
remaining sequences were mapped using Bismark (v0.14.4) (Krueger and Andrews, 2011) 783 
with default parameters to the mouse reference genome Ensembl v67 NCBIM37 in paired-784 
end mode. Reads were then deduplicated and CpG methylation calls were extracted from 785 
the deduplicated mapping output using the Bismark methylation extractor (v0.14.4) in paired 786 
end mode. CpG methylation calls were analysed using R and SeqMonk software 787 
(www.bioinformatics.babraham.ac.uk/projects/seqmonk/). The custom R scripts can be found 788 
in Data S1. Global CpG methylation levels of pooled replicates were calculated in windows of 789 
50 CpGs with a coverage of at least 3, illustrated using bean plots. Methylation over a given 790 
genomic feature was calculated by averaging the individual methylation levels of CpGs 791 
covered by at least 3 reads and only features with at least 50 CpGs were used. Promoters 792 
were defined as the region -1 kb to the transcription start site as annotated in Ensembl 793 
NCBIM37 v67. For analysis of specific genome features these were defined as follows: Gene 794 
bodies (probes overlapping genes), CGI promoters (promoters containing a CGI) (Illingworth 795 
and Bird, 2009), non-CGI promoters (all other promoters).  796 
 797 
RNA-seq mapping and analysis 798 
RNA-seq sequences were trimmed using Trim Galore using default settings. Trimmed 799 
sequencing reads were aligned to mouse genome assembly NCBIM37 using TopHat 800 
(Trapnell et al., 2009) and reads with MAPQ scores <20 were discarded. Mapped RNA-seq 801 
data were quantitated using the RNA-seq quantitation pipeline in SeqMonk software to 802 
generate log2 RPM (reads per million reads of library) expression values. Genes were 803 
considered to be differentially expressed if they were significantly different (p<0.05 after 804 
Benjamini and Hochberg multiple testing correction) when analysed with both DESeq2 and 805 
Intensity difference (SeqMonk) statistical tests. 806 
 807 
Global pervasive transcription, was calculated as following: Genes with significant antisense 808 
expression were identified by initially counting both sense and antisense reads over all genes 809 
in the genome. A global expected antisense level was defined by the total proportion of 810 
antisense reads across all genes. Individual genes were considered to show significant 811 
antisense expression if they had a binomial p-value <0.05 following multiple testing 812 
correction (FDR) using the global antisense proportion as the expected success rate, the 813 
total reads for that gene as the trials and the total antisense reads for that gene as 814 
successes. Additionally, the raw antisense transcription counts for all samples was 815 
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calculated and significant differential antisense expression was calculated using DESeq2 816 
with an FDR < 0.05. The overlap of the two quantifications was used to define pervasive 817 
transcription, and the difference in antisense transcription between WT and KO samples at 818 
each time point was plotted using R.  819 
 820 
ChIP-seq mapping and analysis 821 
ChIP-seq sequencing data was trimmed to remove poor quality reads, adaptor and barcodes 822 
sequences using Trim Galore. Trimmed data were mapped using Bowtie2 (Langmead and 823 
Salzberg, 2012) against the mouse reference genome Ensembl v67 NCBIM37 and reads 824 
with a MAPQ value < 20 were discarded. Mapped ChIP-seq data were quantitated creating 825 
1kb tiles of the whole genome and calculating the log2 observed/expected value comparing 826 
the observed read count with the expected count had all reads been uniformly distributed 827 
over the genome.  828 
 829 
Small RNA-seq mapping and analysis 830 
For small RNA-seq data analysis trimmed sequencing reads were filtered to 20-24nt length 831 
and mapped to the mouse NCBIM37 genome assembly using Bowtie2. Raw overlap counts 832 
for each small RNA molecule were quantitated using SeqMonk. Graphing and statistics was 833 
performed using Excel or R. For consensus sequence mapping the piPipes small RNA 834 
pipeline was used (https://github.com/bowhan/piPipes) (Han et al., 2015). IAPEZ consensus 835 
sequences were used from repeatmasker libraries (repeatmasker v4.0.3, library version 836 
20130422). Additionally, the small RNA-seq data processing was performed using the freely 837 
available piRNA pipeline piPipes. For repeat mapping, trimmed data were mapped using 838 
Bowtie2 against repeats as defined in the analysis by using the mouse repeatmasker 839 
annotation. The plots shown were generated as described below: The distribution of small 840 
RNAs was computed by mapping all small RNA-seq reads to the individual genomic 841 
features. The length distribution was calculated taking all uniquely mapped small RNAs into 842 
account, excluding small RNA-seq mapping to ribosomal RNAs (rRNAs). For all subsequent 843 
analysis, small RNA reads were pre-filtered as follows: reads mapping to rRNAs and 844 
miRNAs were excluded, then reads aligning to the repeat masked mm9 genome (all 845 
annotated repeats were masked/replaced by Ns) were removed, too. The remaining small 846 
RNAs reads were mapped to the mouse repeatmasker annotation. The 5′ end nucleotide 847 
composition was computed from the uniquely mapped small RNAs. Similarly, analysis of the 848 
position of 5′ to 5′ overlap was performed on the mapped small RNAs reads and the length 849 
distribution and strand orientation of small RNAs shown was generated using uniquely 850 
mapped small RNA reads. 851 
 852 
Transposon analysis  853 
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Repeat locations for a pre-defined set of repeat classes of interest were extracted from the 854 
pre-masked repeatmasker 4.0.3-20130422 library in the mm9 genome. Repeat instances 855 
within 2 kb of an annotated gene in the Ensembl v67 NCBIM37 gene set were removed to 856 
avoid mixing signals from genic expression with specific expression of repetitive sequences. 857 
RNA-seq data were processed and mapped as described above (RNA-Sequencing Mapping 858 
and Analysis). We set a standard outlier filtering approach with a cutoff of counts > 3. 859 
Overlaps were quantitated between the mapped RNA-seq reads and the repeat instances. 860 
This allowed an unbiased identification of TEs depending on Dnmt1 KO as well as Dicer KO, 861 
which we followed throughout this manuscript. Summed counts for all instances of each 862 
class of repeat were calculated and these were corrected for both the total length of all TEs 863 
and the size of the individual libraries to generate log2 RPM expression values. The matrix of 864 
expression values and samples were plotted using the R pheatmap library allowing the 865 
repeat classes to cluster using default parameters. WGBS-seq libraries were processed and 866 
mapped as described below (Bisulfite Sequencing Mapping and Analysis). Methylation levels 867 
at the repeat instances were quantitated by summing up all methylation calls and non-868 
methylation calls for all instances of each class of repeat and calculating the percentage of 869 
methylated Cs over all Cs. Only TEs with at least 1000 observations in all samples were 870 
used for the analysis and calculation of percentage methylation. For major satellite 871 
methylation analysis Bismark (Krueger and Andrews, 2011) was used to map all reads 872 
against the mouse major satellite consensus sequence (GSAT from repeatmasker) and the 873 
methylation calls from these results were analyzed directly. The custom R scripts can be 874 
found in Data S1. 875 
 876 
Statistics 877 
Statistical values including the exact number of replicates (n), the definition of standard 878 
deviation and statistical significance are reported in the Figure Legends.  879 
(1) WGBS-seq 880 
For statistical analysis WGBS-seq of Figure 1A and S1 of WT versus Dnmt1 KO data we 881 
used the Wilcoxon rank sum test with Bonferroni correction testing with a p-value threshold 882 
of <0.05. The code of the analysis of the retained methylation over TEs can be found in Data 883 
S1. 884 
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(2) Total RNA-seq 885 
To call differentially expressed mRNAs, we applied the SeqMonk intensity difference filter 886 
with Benjamini and Hochberg correction for multiple testing with a p-value threshold of <0.05 887 
and overlapped them with the genes called differentially expressed by DESeq2 with a p-888 
value threshold of <0.05 and multiple testing correction. 889 
For TE analysis we only considered significantly differentially expressed TEs p<0.05 of 890 
Dnmt1 KO over WT samples into account. The code of the analysis can be found in Data S1. 891 
(3) small RNA-seq 892 
To call differentially expressed miRNAs we overlapped the differentially expressed miRNAs 893 
using DESeq2 with multiple testing correction and SeqMonk intensity difference filter with 894 
Benjamini and Hochberg correction with a p-value of <0.05. 895 
To call differential amount of mapped small RNAs to TEs we used Students t-test to compare 896 
day 8 to day 0 enrichment of small RNAs with a p-value of <0.05. 897 
(4) ChIP-seq 898 
As we only have data from one measurement we could not call significant differences of 899 
histone modification enrichment but show TEs which have at least 2 times higher enrichment 900 
in Dnmt1 KO versus WT samples. The code of the analysis can be found in Data S1. 901 
(5) RT-qPCR 902 
Each RT-qPCR was done with 3 technical replicates. Differences between conditions that 903 
are statistically significant are denoted by *p-value<0.05, **p-value<0.005 using the standard 904 
distributed two tailed t-test.  905 
(6) siRNA knock-down 906 
Every siRNA knock-down was done in 3 technical replicates. Differences between conditions 907 
that are statistically significant are denoted by *p-value<0.05, ** p-value<0.005 using the 908 
standard distributed two tailed t-test. 909 
 910 
DATA AND SOFTWARE AVAILABILITY 911 
The accession numbers for the next-generation-sequencing data reported in this study are 912 
GEO: GSE89698.The software of this study can be found in Data S1. 913 
 914 
 KEY RESOURCES TABLE 
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
anti-CD4 microbead Miltenyl Biotec Cat #: 130-045-101 
Alexa Fluor 647, goat anti-mouse IgG antibody Thermo Fisher Scientific Cat# A-21236 
RRID:AB_141725 
Alexa Fluor 568 donkey anti - rabbit IgG antibody Thermo Fisher Scientific Cat# A10042 
RRID:AB_2534017 
Rabbit Anti-Nanog Polyclonal Antibody, Unconjugated Abcam Cat# ab80892 
RRID:AB_2150114 
AGO2 antibody  Dr. O’Carrolls lab  
Histone H3K9me3 antibody Active Motif Cat #: 61013, RRID: 
AB_2687870 
H3K27me3-mouse antibody Active Motif Cat #:  39155, 
RRID:AB_2561020 
Histone H3K9me2 antibody Abcam Cat #: ab1220, 
RRID:AB_449854 
Bacterial and Virus Strains  
E.coli: One Shot™ TOP10 chemically competent cells Thermo Fisher Scientific Cat #: K450001 
Chemicals, Peptides, and Recombinant Proteins 
Tamoxifen Sigma-Aldrich Co. Ltd Cat #: T5648-1G 
mouse LIF Stem Cell Institute, 
Cambridge 
N/A 
Na/Deoxycholate Sigma-Aldrich Co. Ltd Cat #: D6750-10G 
N-lauroylsarcosine Sigma-Aldrich Co. Ltd Cat #: 61739-5G 
Vanadyl ribonucleoside complex New England Biolabs Cat #: S1402S 
Lipofectamine 2000 Thermo Fisher Scientific Cat #: 11668027 
Protein G-coupled Dynabeads Thermo Fisher Scientific Cat #:  10003D 
HiFi Uracil+ ReadyMix KAPABiosystems Cat #: KK2801 
T4 RNA Ligase 2, truncated New England Biolabs Cat #: M0242S 
Tri-Reagent Sigma-Aldrich Co. Ltd Cat #: T9424-200ML 
Phenol/chloroform/isoamylalcohol (25:24:1) Life Technologies Ltd Cat #: 15593031 
TritonX 100 Sigma-Aldrich Co. Ltd Cat #: RES9690T 
Dimethylsulfoxide (DMSO) Thermo Fisher Scientific Cat #: TS-20684 
Ampicillin Sigma-Aldrich Co. Ltd Cat #: A9518-5G 
Penicillin/Streptomycin Thermo Fisher Scientific Cat #: 15140122 
L-glutamine Thermo Fisher Scientific Cat #: 25030081 
Non-essential amino acids Thermo Fisher Scientific Cat #: 11140050 
2-Mercaptoethanol (50mM) Life technologies Cat #: 31350-010                       
RNase A Thermo Fisher Scientific Cat #: EN0531 
cOmplete™ Protease Inhibitor Cocktail Sigma-Aldrich Co. Ltd Cat #: 00000001169 
7498001 
Proteinase K Thermo Fisher Scientific Cat #: EO0491 
Paraformaldehyde 16% Solution Agar Scientific Cat #: AGR1026 
Gelatine Sigma-Aldrich Co. Ltd Cat #: G9391 
DTT Sigma-Aldrich Co. Ltd Cat #: D0632-1G 
Fetal Bovine Serum (FBS) Stem Cell Institute, 
Cambridge 
N/A 
Key Resource Table
 DMEM (High Glucose) w/L-Glutamine andamp; Na Pyr  Life technologies Cat #: 41966-052 
NEBuffer 2 New England Biolabs Cat #: B7002S 
Trypsin EDTA (1x) 100ml Life technologies Cat #: 25300-054 
HyperLadderTM 1kb, 100bp Bioline Cat #: BIO-33053, 
BIO-33029 
SYBR Safe Invitrogen Cat #: S33102 
SYBR Gold Life Technologies Ltd. Cat #: S11494 
PvuI New England Biolabs Cat #: R0150S 
EcoRI HF New England Biolabs Cat #: R3101L 
T4 Polynucleotide Kinase New England Biolabs Cat #: M0201L 
T4 Ligase New England Biolabs Cat #: M0202T 
Ampure XP beads Beckman Coulter Cat #: A63880 
T5 Exonuclease New England Biolabs Cat #: M0363S 
Exonuclease I New England Biolabs Cat #: M0293S 
Klenow exo- New England Biolabs Cat #: M0212L 
Glycoblue Ambion Cat #: AM9516 
Optimem Gibco Cat #: 31985062 
DAPI Thermo Fisher Scientific Cat #: 62248 
MyTaq Redmix Bioline Cat #: BIO-25043 
Orange G dye Sigma-Aldrich Co. Ltd Cat #: 861286-25G 
Critical Commercial Assays 
TruSeq Small RNA Library Prep Kit -Set A (24 rxns) (Set 
A-c: indexes 1-36) 
Illumina Cat #:RS-200-0012, 
RS-200-0024, RS-
200-0036 
NEBNext® DNA Library Prep Master Mix Set for 
Illumina® 
New England Biolabs Cat #: E6040S 
Imprint ® DNA Modification Kit Sigma-Aldrich Co. Ltd Cat #: MOD50-1KT 
TruSeq RNA library preparation kit v2 Illumina Cat #: RS-122-2001 
MicroPlex Library Preparation kit Diagenode Cat #: C05010012 
SmallRNA qRTPCR miRNA kit: mmu_miR93 Taqman Cat #: TM001090 
SmallRNA qRTPCR miRNA kit: mmu_miR7081_mat Taqman Cat #: 
TM467052_mat 
SmallRNA qRTPCR miRNA kit: snoRNA202 Taqman Cat #: 001232 
Dharmacon siGENOME SMARTpool, mouse Dicer Dharmacon Cat #: MU-040892-
01-0005 
Dharmacon siGENOME SMARTpool, mouse Dgcr8 Dharmacon Cat #: MU-051365-
00-0002 
Dharmacon siGENOME SMARTpool, mouse Ago2 Dharmacon Cat #: MU-058989-
01-0005 
Dharmacon siGENOME SMARTpool, mouse Dicer Dharmacon Cat #: D-001210-02-
05 
Miniprep kit Qiagen Cat #: 27106 
Gel extraction kit GeneJET Cat #: K0691 
PCR Purification kit GeneJET Cat #: K0701 
Qiaamp DNA micro kit Qiagen Cat #: 56304 
TURBO DNA-free kit Life Technologies Ltd Cat #: AM1907 
Quant-iT PicoGreen® dsDNA Assay kit Life Technologies Ltd Cat #: P11496 
Platinum SYBR Green qPCR SuperMix-UDG w/ROX Life Technologies Ltd Cat #: 11744100 
QuickExtract Epicentre Cat #: QE09050 
Kapa Library Quantification kit Kapa Biosystems Cat #: KK4847 
 High Sensitivity DNA kit Agilent Cat #: 5067-4626 
High Sensitivity total RNA kit Agilent Cat #: 5067-1513 
Deposited Data 
Raw and analyzed data  This study GEO: GSE89698 
Mouse reference genome NCBI build 37, NCBIM37 Mouse Genome 
Sequencing Consortium 
http://may2012.archi
ve.ensembl.org/Mus
_musculus/Info/Inde
x 
Mouse repeats repeatmasker v4.0.3, 
library version 20130422 
http://www.repeatma
sker.org/ 
Mouse ESCs enhancer annotation track Chen et al., 2012, 
Creyghton et al., 2010 
 
CpG island promoters Illingworth and Bird, 2009  
Promoters: regions -1kb to the transcription start site Ensemble, NCBIM37 
version 67 
 
Experimental Models: Cell Lines 
Dnmt1 cKO: Passage 12 Dnmt1loxP/loxP (C57BL/6) ESCs Sharif et al., 2016 N/A 
Dicer/Dnmt1 cDKO: Passage 21 Dicer loxP/loxP/Dnmt1 
loxP/loxP ESCs  
This study See STAR methods 
for details  
Ago2/Dnmt1 cDKO: Passage 21 Ago2 loxP/loxP /Dnmt1 
loxP/loxP ES cells  
This study See STAR methods 
for details 
Dicer KO: Passage 17 Dicer KO/Dnmt1 loxP/loxP ES cells This study See STAR methods 
for details 
Ago2 KO: Passage 17 Ago2 KO/Dnmt1 loxP/loxP ES cells This study See STAR methods 
for details 
Experimental Models: Organisms/Strains 
Mouse: C57Bl/6J female mice carrying the Oct4-GFP 
transgene in the developing gonad: B6.Cg-
Tg(GOF18/EGFP)11Ymat/Rbrc 
Yoshimizu et al., 1999 RRID:IMSR_RBRC0
0868 
Oligonucleotides 
Primers for CRISPR clone generation, see Table S3 This paper N/A 
Primers for RTqPCR clone generation, see Table S2 This paper N/A 
Recombinant DNA 
Cas9 plasmid: pSpCas9(BB)-2A-GFP Ran et al., 2013 Addgene Plasmid 
#48138 
pSpCas9(BB)-2A-hCD4 This study N/A 
Software and Algorithms 
Bowtie2 Langmead and Salzberg, 
2012 
http://bowtie-
bio.sourceforge.net/
bowtie2/index.shtml 
Bismark Krueger and Andrews, 
2011 
https://www.bioinfor
matics.babraham.ac
.uk/projects/bismark/
, version 0.14.4 
TopHat Trapnell et al., 2009 http://ccb.jhu.edu/sof
tware/tophat/index.s
html 
piPipes Han et al., 2015 https://github.com/b
owhan/piPipes/wiki 
 Trim Galore N/A http://www.bioinform
atics.babraham.ac.u
k/projects/trim_galor
e/, Version 0.4.1 
SeqMonk software N/A www.bioinformatics.
babraham.ac.uk/proj
ects/seqmonk/ 
DESeq2 Love et al., 2014 https://bioconductor.
org/packages/releas
e/bioc/html/DESeq2.
html, version 3.5 
Transposon analysis this study supplement 
R Data analysis https://www.r-
project.org/, version 
3.2.5 
Adobe Illustrator Figures http://www.adobe.co
m/de/products/illustr
ator.html, version 
CC 2015.3 
Other 
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Supplemental Information 1	
 2	
Supplemental Figure Legends 3	
Figure	 S1.	 Global	 DNA	 demethylation	 and	 transcriptional	 change	 upon	 acute	 Dnmt1	 deletion,	4	
Related	to	Figure	1	5	
(A) WGBS-seq reads overlapping the whole Chromosome 2 between WT (day 1-day 11) and 6	
Dnmt1 cKO ESCs induced for 1-11 days. Percentage of methylated cytosines were counted 7	
for each consecutive 50 CpG window genome-wide. 8	
(B) Enrichment of CpG methylation over transcription starts sites (TSS) and gene body in WT 9	
and Dnmt1 cKO ESCs induced 1 day (dark red), 3 days (light red), 6 days (light pink), 9 days 10	
(light blue), 11 days (dark blue). Measurement of 2 biological replicates. Percentage of 11	
methylated cytosines were counted for each consecutive 50 CpG window genome-wide. 12	
(C) Bean plots showing distribution of methylation levels for genome features between WT 13	
(grey) and conditional Dnmt1 cKO ESC induced for 1 day (dark red), 3 days (light red), 6 14	
days (light pink), 9 days (light blue), 11 days (dark blue). Low methylated regions (LMRs) 15	
(Stadler et al., 2011), enhancers defined by H3K4m1 (Chen et al., 2012) and H3K27ac  16	
(Creyghton et al., 2010). Measurement of 2 biological replicates. For significance analysis 17	
Wilcoxon rank sum test with Bonferroni correction testing with a p-value threshold of < 0.05. 18	
(D) Chromosome view of RNA-seq reads over mRNA with Lx5 or MIRb TE sitting in the 2kb 19	
surrounding region of a coding gene. RNA-seq libraries are strand specific. Each read is 20	
depicted. 21	
(E) Violin plots showing distribution of methylation levels for different TE classes between 22	
WT (grey) and conditional Dnmt1 cKO ESC induced for 1 day (dark red), 3 days (light red), 6 23	
days (light pink), 9 days (light blue), 11 days (dark blue). Measurement of 2 biological 24	
replicates. For significance analysis Wilcoxon rank sum test with Bonferroni correction testing 25	
with a p-value threshold of < 0.05. 26	
(F) Graphs showing methylation retention of TE classes in comparison to the rest of the 27	
genome, (left) scatter plot of WGBS sequencing reads in gradient of grey with specific TE 28	
class as red dot, (right) line graph of TE class in time course (red) in comparison to probes 29	
starting with the same methylation level as the respective TE class (blue) and in comparison, 30	
to the rest of the genome (grey). Measurement of 2 biological replicates.  31	
(G) Scatter plot of all reads overlapping genes in the genome with the significantly Dnmt1 32	
responsive genes highlighted in black. Significance was called by combining both Intensity 33	
difference (SeqMonk) as well as DESeq2 significance called genes with a p-value threshold 34	
of < 0.05 and multiple testing correction. 35	
(H) Venn Diagram of the number and overlap of mRNAs upregulated upon Dnmt1 cKO. 36	
Supplemental Text and Figures
2	
(I) Bar graph of 6 genes in WT which were most highly upregulated and downregulted upon 37	
Dnmt1 cKO induced 0 days (black), 1 day (dark red), 3 days (light red), 6 days (light pink), 9 38	
days (light blue), 11 days (dark blue). Dots show the expression level in the 2 RNA-seq 39	
libraries for each time point.  40	
(J) Bar plots of expression of key pluripotency genes between WT (grey) and conditional 41	
Dnmt1 cKO ESC not induced (black), induced for 1 day (dark red), 3 days (light red), 6 days 42	
(light pink), 9 days (light blue). Measurements of 2 biological replicate shown next to each 43	
other.  44	
(K) Bar plot showing percentage of genic insertions of Dnmt1 and Dicer responsive TEs in 45	
sense (red) and antisense (blue) direction to the respective genes.  46	
	 47	
Figure	S2.	Genome	wide	small	RNA	response	upon	Dnmt1	conditional	KO,	Related	to	Figure	2	48	
(A) Bar plots of small RNA size distribution as well as classification of different small RNA 49	
classes in Dnmt1 cKO and WT ESCs mapped to the whole genome; miRNAs (grey), rRNA 50	
(green), small nuclear RNAs (snRNAs) (violet), miscellaneous other RNAs (misc RNAs) 51	
(red), small nucleolar RNAs (snoRNA) (orange) and tRNA (light blue) of WT (right) and after 52	
conditional Dnmt1 cKO (left).  53	
(B) Expression of endogenously transcribed miRNAs in WT (grey) and in conditional Dnmt1 54	
cKO induced for 1 day (dark red), 3 days (light red), 6 days (light pink), 9 days (light blue), 11 55	
days (dark blue). Error bars represent mean +/-SD of 3 technical replicates. 56	
(C) Genic location of miRNA 200c with reads mapped in Dnmt1 cKO and WT ESCs, each 57	
line representing one read.  58	
(D) Scatter plot of all small RNAs in the genome, highlighting miRNAs of the Dlk cluster 59	
(black) and Xlr3 cluster (green) at day 9 after Dnmt1 cKO (y-axis) versus WT (x-axis). 60	
Significance was called by combining both Intensity difference (SeqMonk) as well as 61	
DESeq2 significance called genes with a p-value threshold of < 0.05 and multiple testing 62	
correction. 63	
(E) Bar graph of 2 representative small RNAs of the Xlr3 and Dlk locus in WT and upon 64	
Dnmt1 cKO induced 1 day (dark red), 3 days (light red), 6 days (light pink), 9 days (light 65	
blue), 11 days (dark blue). Error bars represent mean +/-SD of 3 technical replicates. 66	
Statistics: two-sided Students t-test, * p-value <0.05, ** p-value <0.005, *** p-value <0.0005. 67	
(F)	 Confirmation of small RNA-seq data by small RNA RT-qPCR, (left) Bar plot showing 68	
small RNA RT-qPCR of mmu-miR-543 and mmu-miR-367 in WT (grey) and conditional 69	
Dnmt1 cKO induced for 9 days (dark red). Error bars represent mean +/-SD of 3 technical 70	
replicates. Statistics: two-sided Students t-test, * p-value <0.05, ** p-value <0.005, *** p-71	
value <0.0005. 72	
3	
(G) Chromosome view of WGBS-seq, total RNA-seq and small RNA-seq depicted as wiggle 73	
plots overlapping imprinted control regions (ICR), mRNA and small RNAs in WT and at day 9 74	
after Dnmt1 deletion. 75	
(H) Pie chart distribution showing mapping of small RNA-seq from AGO2 IP 9 days after 76	
conditional Dnmt1 to different small RNA classes. miRNAs (black), repeats (dark green), 77	
3’UTRs (yellow), introns (dark blue), piRNAs (light blue), 5’UTRs (light green), others (grey).  78	
(I) Bar plot showing small RNA duplex 5’ to 5’ overlap of AGO2 IP small RNA-seq mapping to 79	
repeats after conditional Dnmt1 cKO induced 9 days.  80	
(J) Bar plot showing nucleotide position 30 nt upstream and downstream of 5’ end of AGO2 81	
IP small RNA-seq libraries mapping to repeats after conditional Dnmt1 cKO induced 9 days. 82	
(K) Small RNA-seq of 20-24 nt small RNAs mapped to TEs in vivo PGCs of E13.5 as well as 83	
E14.5 male (blue) and female (red) PGCs. Each library was done as 1 replicate.  84	
(L) Pie chart distribution of small RNAs mapping to different genomic loci of in vivo E14.5 85	
male PGC small RNA-seq libraries after conditional Dnmt1 cKO induced 9 days. miRNAs 86	
(black), repeats (dark green), 3’UTRs (yellow), introns (dark blue), 5’UTRs (light green), 87	
rRNA_tRNA (grey), unannotated (white).  88	
(M) Size distribution for in vivo E14.5 male PGCs of sense (blue) and antisense (red) small 89	
RNAs mapping to repeatmasker consensus sequences using piPipes small RNA pipeline.  90	
(N) Bar plot showing siRNA duplex 5’ to 5’ overlap for in vivo E14.5 male PGC small RNA-91	
seq libraries mapping to repeats.  92	
(O) Bar plot showing nucleotide position 30 nt upstream and downstream of 5’ end of in vivo 93	
E14.5 male PGC small RNA-seq library mapping to repeats. 94	
 95	
Figure	S3.	Characterisation	of	the	involvement	DICER	and	AGO2	in	TE	silencing,	Related	to	Figure	3 96	
(A) (left) Schematic showing Dicer conditional cKO generation using CRISPR by introducing 97	
loxP sites into Intron 14_15 and Intron 20_21. Agarose gel of PCR to screen for genomic 98	
recombination of 2 Dicer/Dnmt1 conditional double cKO clones after addition of 4OHT for 3 99	
days. Recombination of Intron 15-16 was tested with primer set 1, recombination of intron 100	
20-21 was tested with primer set 2 and recombination of both introns was tested with primer 101	
set 3, LD = 1000 bp DNA ladder. (middle) RT-qPCR of Dicer mRNA upon CRE 102	
recombination induced by tamoxifen (4OHT) in clone 1 (light green) and clone 2 (dark green) 103	
of Dicer conditional KO ESCs. Error bars represent mean +/-SD of 3 technical replicates. 104	
Statistics: two-sided Students t-test, * p-value <0.05, ** p-value <0.005, *** p-value <0.0005. 105	
(right) RT-qPCR of mmu-miR-93 expression in ESCs upon Dicer KO in clone 1 (light green) 106	
and clone 2 (dark green) controlled by snoRNA expression. Error bars represent mean +/-SD 107	
of 3 technical replicates. Statistics: two-sided Students t-test, * p-value <0.05, ** p-value 108	
<0.005. 109	
4	
(B) Bar graph of percentage of genic antisense transcription over the time course of 110	
Dicer/Dnmt1 cDKO, Dicer KO and Dnmt1 cKO in KO over WT samples. Measurement of 2 111	
biological replicates for Dicer/Dnmt1 cDKO and Dnmt1 cKO and WT samples and 1 replicate 112	
for Dicer KO ESCs. 113	
(C) Bar plots of small RNA size distribution as well as classification of different small RNA 114	
classes in Dicer/Dnmt1 cDKO, Dnmt1 cKO with KO induced for 4 days and Dnmt1fl/fl mESCs 115	
and WT mapped to the whole genome; miRNAs (light blue), rRNA (grey), small nuclear 116	
RNAs (snRNAs) (dark blue), miscellaneous other RNAs (misc RNAs) (orange), small 117	
nucleolar RNAs (snoRNA) (yellow) and tRNA (light green). 118	
(D) Small RNA-seq of Dicer/Dnmt1 cDKO and Dnmt1 cKO ESCs normalised to WT ESCs 119	
mapped to IAPEz and L1MdGf TE classes. *p<0.05, **p<0.005, two-tailed student t-test. 120	
Measurement of 2 biological replicates.  121	
(E) Schematic showing Ago2 conditional cKO generation using CRISPR by introducing loxP 122	
sites into Intron 8_9 and Intron 11_12 of Ago2 mRNA. Agarose gel of PCR to screen for 123	
genomic recombination of four Ago2/Dnmt1 conditional double cKO clones after addition of 124	
4OHT for 3 days in comparison to one WT clone. Recombination of Intron 8-12 was tested 125	
with primer set 1. LD = 100 bp DNA ladder. 126	
(F) RT-qPCR analysis of Ago2 in ESCs following conditional Ago2/Dnmt1 cDKO by 127	
treatment with 4OHT or control (EtOH) for 3 days. Error bars represent mean +/-SD of 3 128	
biological replicates in 3 technical replicates. Values were normalized to Hspcb and 129	
controlled to EtOH samples. Statistics: two-sided Students t-test, * p-value <0.05, ** p-value 130	
<0.005. 131	
(G) Immunofluorescence of AGO2 protein (purple) in Ago2/Dnmt1 cDKO and Dnmt1 cKO 132	
ESCs upon KO induction with 4OHT. Deletion was induced for 3 or 8 days as depicted. 133	
Nuclear DAPI counter staining (white). scale bar = 20μm.  134	
(H) (upper panel) Schematic knock out strategy for Dicer in mouse ESCs constructing 135	
gRNAs against Exon 23 and 24 of Dicer mRNA. gRNA Protospacer Adjacent Motif (PAM) 136	
sequences (dark blue). (Bernstein et al., 2003), (lower left) RT-qPCR of mRNA expression of 137	
Dicer in WT (black) and Dicer cKO (dark blue). Error bars represent mean +/-standard 138	
deviations of 3 technical replicates. Statistics: two-sided  Students t-test, * p-value <0.05, ** 139	
p-value <0.005, *** p-value <0.0005, (lower right) Expression level of mmu-miR-93 in 140	
wildtype (black) and Dicer cKO (dark blue). Error bars represent mean +/-standard deviations 141	
of 3 technical replicates. Statistics: two-sided  Students t-test, * p-value <0.05, ** p-value 142	
<0.005, *** p-value <0.0005, 143	
(I) (upper panel) Schematic of knock out strategy for Ago2 in mouse ESCs constructing 144	
gRNAs against Intron 13-14 and 115 of Dicer mRNA. gRNA PAM sequences (light green). 145	
(lower panel) RT-qPCR of Ago2 expression in 2 clones of Ago2 KO ESCs (dark purple) in 146	
5	
comparison to Dnmt1fl/fl ESCs (black). Error bars represent mean +/-standard deviations of 3 147	
technical replicates. Statistics: two-sided  Students t-test, * p-value <0.05, ** p-value <0.005, 148	
*** p-value <0.0005, 149	
(J) Immunofluorescence of AGO2 protein (purple) and NANOG (green) in Ago2 KO/Dnmt1 150	
cKO and mouse embryonic fibroblasts. Nuclear DAPI counter staining (white). scale bar = 151	
20μm. Differences of Ago2 KO versus WT were analysed using FIJI and manual ROIs to 152	
semi-quantify the Ago2 signal intensity in the cells. The mean intensity (to correct for different 153	
cell size) was analysed and statistically significant was calculated in GraphPad (Students t-154	
test, p-value <0.0005). 155	
(K) Bar plots of expression of 5 pluripotency genes between WT (grey) and conditional 156	
Dnmt1 cKO ESC induced for 11 days (dark blue), Dicer KO (light blue) treated with EtOH for 157	
1 day and 11 days, Dicer KO/Dnmt1 DKO (faint blue) treated with 4OHT for 1 and 11 days.  158	
(L) Scatter plot of RNA-seq data of Dicer KO (y-axis) versus WT (x-axis) ESCs. Differentially 159	
expressed genes were called by intensity difference of SeqMonk (black), all other genes are 160	
depicted in grey.  161	
(M) Chromosome view of read count quantitation across the 4 genes Lin28, Dnmt3l, Fbln2 162	
and Oct4. High bars indicated high expression, low bars indicate low expression. Every bar 163	
overlaps at least 1 read. 164	
(N) RT-qPCR data of LINE and major satellites in Dicer KO/Dnmt1 cKO following conditional 165	
Dnmt1 cKO, by treatment with 4OHT. Error bars represent SD of 3 technical replicates. 166	
Values were normalized to Atp5b, Hspcb and Major satellites to U1. Error bars represent 167	
mean +/-standard deviations of 3 technical replicates. Statistics: two-sided Students t-test, * 168	
p-value <0.05, ** p-value <0.005, *** p-value <0.0005, 169	
(O) Heatmap of unbiased hierarchical clustering of all TE classes responsive Dicer 170	
KO/Dnmt1 cKO versus Dnmt1 cKO. Heatmap is showing relative expression (z-score) of TEs 171	
upon Dnmt1 cKO and were generated using the pheatmap R library.  172	
 173	
Figure	S4.	Distribution	of	 repressive	histone	marks	–	H3K9me3,	H3K9me2	and	H3K27me3	 in	ESCs	174	
upon	Dnmt1	cKO,	Related	to	Figure	4	175	
(A)	 Pie chart of enrichment of H3K27me3, H3K9me3 and H3K9me2 in repeats (dark violet), 176	
genic regions (light violet), promoters (dark green), CGIs (middle green), intergenic regions 177	
(light green) in wildtype ESCs. 178	
(B) Probe enrichment of H3K9me3 (green), H3K9me2 (yellow) and H3K27me3 (blue) over 179	
gene body and TSS. 180	
(C) Aligned probe plot of H3K27me3 enrichment surrounding 5kb of TSS. 181	
(D)	 Scatter plot of repressive histone marks overlapping genes in wildtype (y-axis) versus 182	
Dnmt1 cKO (x-axis) ESCs. 183	
6	
(E) Wiggle plot of ChIP enrichment of H3K9me3 (green), H3K27me3 (blue) and H3K9me2 184	
(yellow) over a 500kbp region in Chromosome 12. Intensity of the enrichment on the y-axis. 185	
(F) Wiggle plot of H3K9me3 enrichment over IAPEZ in Dnmt1 cKO at day 4 (red), day 8 186	
(blue) and in WT (grey). Plots were generated using SeqMonk wiggle-plot quantitation. 187	
(G)	Bar graph of enrichment of H3K27me3, H3K9me3 and H3K9me2 in repeats (dark violet), 188	
genic regions (light violet), promoters (dark green), CGIs (middle green), intergenic regions 189	
(light green) in WT ESCs, Dnmt1 cKO, Dicer KO and Dicer/Dnmt1 cDKO 190	
(H) Wiggle plot of ChIP-seq enrichment of H3K9me3, H3K27me3 and H3K9me2 at three 191	
genomic loci in Dicer/Dnmt1 cDKO at day 11 (light blue), Dicer KO (middle blue), Dnmt1 cKO 192	
at day 11 (dark blue) and WT (grey). Enrichment intensity shown on y-axis. 193	
(I) Summary of TE classes across WGBS-seq, RNA-seq, small RNA-seq and ChIP-seq 194	
libraries. Scale from red (loose) to green (gain). 	195	
 196	
 197	
Supplemental Tables 198	
Table	S1:	List	of	differentially	expressed	genes	upon	Dnmt1	KO	and	Dicer	KO,	Related	to	Figure	1	199	
and	S1	and	Figure	3	and	S3.	200	
Differentially expressed genes were called using the overlap between the SeqMonk Intensity 201	
difference as well as DESeq2.  202	
	203	
Table	S2:	RT-qPCR	primers,	Related	to	Figure	3	and	S3	204	
Primers below have been used for expression analyses (RT-qPCR primers).  205	
 206	
Table	S3:	CRISPR	primers,	Related	to	Figure	3,	S3	207	
CRISPR primers were used to construct Dicer KO/Dnmt1 cKO and Dicer/Dnmt1 cDKO, Ago2 208	
KO/Dnmt1 cKO and Ago2/Dnmt1 cDKO mouse ES cells. gRNA (guide RNA). 209	
	210	
Supplemental Data 211	
Data S1: Raw code to analyse TEs, Related to Figure 1-4. 212	
 213	
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Table	S2:	RT-qPCR	primers,	Related	to	Figure	3	and	S3		
Gene Primer Sequence origin 
Hspcb msRT_Hspcb_FW GCTGGCTGAGGACAAGGAGA  
 msRT_Hspcb_RV CGTCGGTTAGTGGAATCTTCATG  
Atp5b msRT_Atp5b_FW GGCCAAGATGTCCTGCTGTT  
 msRT_Atp5b_RV GCTGGTAGCCTACAGCAGAAGG  
Dicer Dicer_RT_17_18_FW GCATTCCTAGCACCAAGTATTCA This study 
 Dicer_RT_17_18_RV GGAAGGAAATTTACTGAGTGGGG This study 
 Dicer_RT_FW GAACGAAATGCAAGGAATGGA  
 Dicer_RT_RV GGGACTTCGATATCCTCTTCTTTCTC  
Ago2 Eif2c2_FW GCCGTCCTTCCCACTACCAC  
 Eif2c2_RV GGTATTGACACAGAGCGTGTGC  
Dgcr8 Dgcr8_FW CCTAAAGACAGTGAAGAACTGGAGTA  
 Dgcr8_RV CATGGAGGATCTGATATGGAGAC  
IAP IAP_Nature_qPCR_FW AAGCAGCAATCACCCACTTTGG (ref) 
 IAP_Nature_qPCR_RV CAATCATTAGATGTGGCTGCCAAG (ref) 
MERVL MuERV-L gag_Jafar_FW TTCTTCTAGACCTGTAACCAGACTCA (Sharif et al., 2016) 
 MuERV-L gag_Jafar_RV TCCTTAGTAGTGTAGCGAATTTCCTC 
(Sharif et 
al., 2016) 
Etn MusD_Nature_qPCR_FW GTGGTATCTCAGGAGGAGTGCC  
 MusD_Nature_qPCR_RV GGGCAGCTCCTCTATCTGAGTG  
U1 U1_AP_FW CTTACCTGGCAGGGGAGATA  
 U1_AP_FW CAGTCCCCCACTACCACAAA  
Maj. Sat. MajSat_BL_FW GACGACTTGAAAAATGACGAAATC  
 MajSat_BL_RV CATATTCCAGGTCCTTCAGTGTGC  
MMERVK10C MmERVK10C_FW ATGTGAGCTAGCTGTTAAAGAAGGAC  
 MmERVK10C_RV CTCTCTGTTTCTGACATACTTTCCTGT  
LINEI LINE ORF2_JS_FW GACATAGACTAACAAACTGGCTACACAAAC (Sharif et al., 2016) 
 LINE ORF2_JS_RV GGTAGTGTCTATCTTTTTCTCTGAGATGAG 
(Sharif et 
al., 2016) 
	
	 	
Table	S3:	CRISPR	primers,	Related	to	Figure	3	and	S3	
Gene Primer Sequence (5’-3’)  
U6 U6-Fwd GAGGGCCTATTTCCCATGATTCC PCR screen 
Dicer KO / 
Dnmt1 cKO 
Dicer1_X23_gRNA_FW CACCGAGTAATCAAAAGGACCAGCC gRNA 
Dicer1_X23_gRNA_RV AAACGGCTGGTCCTTTTGATTACTC gRNA 
Dicer1_X24_gRNA_FW CACCGTTACCAGCGCTTAGAATTCC gRNA 
Dicer1_X24_gRNA_RV AAACGGAATTCTAAGCGCTGGTAAC gRNA 
Dicer_23_24_screen_FW AGCAGTGCATTGCTGACAAGAG PCR screen 
Dicer_23_24_screen_RV CTTGTGGTAGTCATACTTCACAGCC PCR screen 
Dicer/Dnmt1 
cDKO 
Dicer_14_15_gRNA_FW CACCGCACTCAGCATCGAGTCTCG gRNA 
Dicer_14_15_gRNA_RV AAACCGAGACTCGATGCTGAGTGCC gRNA 
Dicer_20_21_gRNA_FW CACCGAGCAATGATCCGGTCTCAGG gRNA 
Dicer_20_21_gRNA_RV AAACCCTGAGACCGGATCATTGCTC gRNA 
Dicer_14_15_RV1 TGAAACCAGACTTCTTCAGCTCG PCR screen 
Dicer_14_15_FW1 CCTTTCCCTCTTGCACATTTACCT PCR screen 
Dicer_2021_FW1 GGTGTCAGATCACTTCCCGT PCR screen 
Dicer_2021_RV1 TGACCAGAATAAGAAGGAGCGGA PCR screen 
Dicer_20_21_donor_loxP 
gacaaggaccactgtactgtttatccctgaagtagcagactagacca
ttgagatcttgtcaagttagagagcagcaagaattctATAACTTC
GTATAGCATACATTATACGAAGTTATgagaccggat
cattgctcctgtagcagtgatgctggaataggggtgagaatggatata
gttcttctcaaaactaa 
Donor DNA 
Dicer_14_15_donor_loxP 
ggcaagaaaagacatttatttctggttgtggggttaaacaaagcagc
agcagcagctcagaaggcactcagcatcgagtctATAACTTC
GTATAATGTATGCTATACGAAGTTATcgatcgaagc
cagagctgcacactgcccaattttacctatgctgcttattacagttttatg
gaatatcaaaagtatttaaaatag 
Donor DNA 
Ago2 KO/ 
Dnmt1 cKO 
Ago2_13_14_gRNA_FW CACCGCTGGTCTAATCATGATCTAA gRNA 
Ago2_13_14_gRNA_RV AAACTTAGATCATGATTAGACCAGC gRNA 
Ago2_14_15_gRNA_FW CACCGAAGCTATTCCTACCCGTCTC gRNA 
Ago2_14_15_gRNA_RV AAACGAGACGGGTAGGAATAGCTTC gRNA 
Ago2_13_14_FW AGGCTACCTTGATGGACATGG PCR screen 
Ago2_14_15_RV GATGGGTTTGGTGGTACATGC PCR screen 
Ago2/Dnmt1 
cDKO 
Ago2_8_9_gRNA_FW CACCGGTTACCTACAAGTTGTGTG gRNA 
Ago2_8_9_gRNA_RV AAACCACACAACTTGTAGGTAACC gRNA 
Ago2_11_12_gRNA_FW CACCGGTTGGTCAGACGGGTCACCG gRNA 
Ago2_11_12_gRNA_RV AAACAGGGTGACTGCCATTTATGAC gRNA 
Ago2_8_9_FW CCTGCTCTTCTGGAGGCATTT PCR screen 
Ago2_8_9_RV CCTGCTCTTCTGGAGGCATTT PCR screen 
Ago2_11_12_FW GTCCAGGGTGTGTGGGACAT PCR screen 
Ago2_11_12_RV GCAACTTCCTCAGCTAATCCTCCA PCR screen 
Ago2_8_9_donor_loxP 
ctcactgtgcacaggtcaagcccagcagagtgccaccaaagctgta
gatggtcctctttcatgccagggttacctacaagAtAtCgtATAAC
TTCGTATAGCATACATTATACGAAGTTATgtgtggtt
gactttggagtggtcccaccactagtcagggttggttctggcttgcgta
ctcagcctctgaaatctccct 
Donor DNA 
Ago2_11_12_donor_loxP 
tgttggtcagacgggtcaccggggttccaataccagcggttggcagc
ctttctctaacagagagcactcacccaggATAACTTCGTATA
GCATACATTATACGAAGTTATgAAtTCgactgccattt
atgagatgtgacaaggccagattaggtgtgagagaaaacagctcct
gagactgtagaaacttcactgtctat 
Donor DNA 
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